Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHG0521 Oral Coating in TSCC
NCT06609070Not yet recruiting
- Sponsor
- Guangzhou University of Chinese Medicine
- Start
- Oct 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of CHG0521 in tongue squamous cell carcinoma, sponsored by Guangzhou University of Chinese Medicine. Primary endpoint: Objective Response Rate at 24 weeks. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
CHG0521
03
Conditions
tongue squamous cell carcinoma
Beyond the preview
Go deeper on NCT06609070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06609070.